Rong Zhang

Rong Zhang

Auto-generated profile, based on publicly available information

Rong Zhang

State Key Laboratory of Neurology and Oncology Drug Development

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2014 in AAPS PharmSciTech
Verified
Journal Article
Open access
PDF file
YFYu Fang
Yu Fang
GWGuozheng Wang
Guozheng Wang
RZRong Zhang
Rong Zhang
ZLZhihua Liu
Zhihua Liu
ZLZhenghua Liu
Zhenghua Liu
DCDeying Cao
Deying Cao
The objectives of the present work were to use blends of Eudragit L and hydroxypropyl methylcellulose acetate succinate (HPMCAS) as enteric film coatings for lansoprazole (LSP) pellets. The...

4 June 2013 in Journal of Chromatographic Science
Verified
Journal Article
Open access
PDF file
XLXiao-Bo Li
Xiao-Bo Li
CLChang-Hui Liu
Chang-Hui Liu
RZRong Zhang
Rong Zhang
XHXiao-Tao Huang
Xiao-Tao Huang
YLYing-Yi Li
Ying-Yi Li
NWNing-Sheng Wang
Ning-Sheng Wang
A sensitive and specific liquid chromatography–tandem mass spectrometric (LC–MS-MS) method was developed for the determination and pharmacokinetics of amygdalin in rats. Rat plasma pretreated by solid-phase extraction was analyzed by LC–MS-MS with negative electrospray ionization in the multiple reaction monitoring mode. Amygdalin and geniposide [the internal standard (IS)] were separated on a C18 column eluted with a mobile phase of methanol and water (85:15; v/v) at a flow rate of 0.25 mL/min in a run time of 3.0 min. The precursor to product ion transitions were monitored at m/z 457.2 → 279.1 for amygdalin and m/z 387.1 → 224.9 for the IS. The calibration curve of amygdalin showed good linearity over a concentration range of 10–2,000 ng/mL. The limit of quantification was 10 ng/mL. Intra-day and inter-day precisions and accuracy (percent relative standard deviation) were both within 10%. The method was fully validated for its selectivity, sensitivity, matrix effect, recovery and stability. This accurate and specific assay produced a useful LC–MS-MS method, which was successfully applied to pharmacokinetic studies after the oral administration of amygdalin to rats.

1 January 2016 in Journal of Nutritional Science and Vitaminology
Verified
Journal Article
Open access
PDF file
RZRong Zhang
Rong Zhang
KWKe-Jia Wu
Ke-Jia Wu
CZCaigui Zhan
Caigui Zhan
Xin LiuXin Liu
Xin Liu
ZGZhiyong Gong
Zhiyong Gong
Folate is a vital vitamin for the human being and its deficiency can lead to a variety of clinical abnormalities ranging from neural tube defects to cancers. Benzo(a)pyrene (BaP), a strong mutagen and carcinogen, is considered one of the common contaminants in food. The aim of this study was to investigate the positive effect of folate on cancer prevention at a fundamental level. In the present study, we investigated the impact of folic acid on BaP-induced mutagenicity and genotoxicity by means of in vitro and in vivo experiments. The reformed Ames test was applied to study the antimutagenicity of folic acid against BaP. The protective effect of folic acid on cytotoxicity caused by BaP in human liver cell line L02 was evaluated by MTT assay. In addition, the effect of folic acid on the BaP-induced genotoxicity in vivo was assessed by mouse bone marrow micronucleus assay. The results indicated that folic acid significantly inhibited the reverse mutation of Salmonella typhimurium strains TA98 and TA100, and protected the viability of human liver cells against BaP (p<0.01). The micronucleus test showed that all doses of folic acid had a remarkable protective effect for the female mice (p<0.01). In conclusion, folic acid was found to reduce the mutagenicity and genotoxicity induced by BaP.

28 April 2025 in Expert Opinion on Drug Metabolism & Toxicology
Verified
Journal Article
Open access
RZRong Zhang
Rong Zhang
RCRui Chong
Rui Chong
SYShaomei Yang
Shaomei Yang
KHKun He
Kun He
QWQing Wen
Qing Wen
The aim of this study was to evaluate the bioequivalence of the test and reference products of ibrutinib capsule (140 mg). This was a fully replicated crossover study that included 100 healthy Chinese volunteers (50 in the fasting BE study and 50 in the fed BE study). Subjects were assigned to receive a single dose of test or reference product in each treatment period. The bioequivalence of main PK parameters (Cmax, AUC0-t, and AUC0-∞) was evaluated using either the average bioequivalence (ABE) approach or the reference-scaled average bioequivalence (RSABE) approach, depending on the within-subject standard deviation of the reference product (SWR) estimated in the study. RSABE approach was applied to Cmax as the corresponding SWR value exceeded the cutoff value of 0.294, while ABE approach was applied to AUC0-t and AUC0-∞ as the corresponding SWR values were less than 0.294. All three PK parameters (Cmax, AUC0-t, and AUC0-∞) met the bioequivalence acceptance criteria in both fasting and fed studies. The test and reference products of ibrutinib capsule are bioequivalent under both fasting and fed conditions. This study also confirmed high intra-subject variability for the Cmax of ibrutinib. http://www.chinadrugtrials.org.cn/index.html identifier is CTR20202168.